GlassScriptPhysician profile
Kenneth H Park
NPI 1609881978
$4,967.96
in general payments reported to CMS, 2019-2025
34 companies · $925 in 2025
The $925 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $180 · 2021: $518 · 2022: $824 · 2023: $897 · 2024: $965 · 2025: $925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,786.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $830.17 | 2019-2025 | Ztlido |
| Collegium Pharmaceutical, INC. | $489.58 | 2019-2025 | Belbuca, Xtampza |
| Amgen INC. | $481.11 | 2022-2024 | Otezla |
| Abbvie INC. | $336.81 | 2022-2025 | |
| Abbott Laboratories | $317.02 | 2019-2025 | Proclaim, Ensite Derexi |
| Zynex Medical, INC. | $258.87 | 2025 | Nexwave |
| Nevro Corp. | $254.81 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $243.96 | 2022-2025 | Relistor |
| Incyte Corporation | $179.01 | 2024 | Opzelura |
| Arbor Pharmaceuticals, INC. | $178.55 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $120.86 | 2024 | Rexulti |
| Axonics, INC. | $120.65 | 2022 | |
| Allergan, INC. | $114.34 | 2021-2022 | |
| Boston Scientific Corporation | $103.17 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.57 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $94.36 | 2025 | Echotip Insight |
| Astrazeneca Pharmaceuticals LP | $93.17 | 2023 | |
| Biodelivery Sciences International, INC. | $92.06 | 2019-2021 | |
| Sentynl Therapeutics, INC. | $79.84 | 2019-2020 | |
| Ibsa Pharma INC. | $66.25 | 2023-2024 | Tirosint, Licart, Licart |
| Electronic Waveform Lab, INC. | $60.96 | 2022 | |
| Biotronik Nro, INC. | $53.04 | 2024-2025 | Prospera |
| Si-Bone, INC. | $46.08 | 2022-2023 | |
| Valinor Pharma, LLC | $43.17 | 2025 | Movantik |
| Lilly USA, LLC | $39.73 | 2020-2022 | |
| Medtronic USA, INC. | $28.79 | 2019-2020 | |
| Medtronic, INC. | $27.88 | 2024 | Intellis Adaptivestim |
| Relievant Medsystems, INC. | $19.52 | 2023 | Intracept |
| Pacira Pharmaceuticals Incorporated | $17.76 | 2025 | Exparel |
| Tonix Medicines, INC. | $17.68 | 2025 | Tonmya |
| Depuy Synthes Sales INC. | $16.62 | 2024 | Monovisc |
| Pfizer INC. | $14.80 | 2019 | |
| Kaleo, INC. | $14.78 | 2019 | |
| Almatica Pharma LLC | $13.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.